» Articles » PMID: 29454886

Development of Neuropathology Following Soman Poisoning and Medical Countermeasures

Overview
Journal Neurotoxicology
Date 2018 Feb 19
PMID 29454886
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Nerve agent-induced seizures can cause varying degrees of neuropathology depending on level of poisoning and duration of seizing. The intention of this review was to validate a novel approach for establishing effective treatment regimens against soman poisoning. Identification of seizure controlling sites in the forebrain of rats poisoned by soman was made by means of lesions, and the anticonvulsive properties of a number of relevant drugs were tested by microinfusions into the identified areas. By using these procedures, procyclidine emerged as the most potent drug. Its potency was confirmed in systemic studies and is further enhanced when combined with levetiracetam. Acute treatment with a combination of HI-6, levetiracetam and procyclidine (procyclidine regimen) can effectively manage supralethal poisoning by any of the classical nerve agents. Extended treatment with the procyclidine regimen is able to terminate residual "silent", local epileptiform activity in the severely poisoned rats. Evident advantages are seen when the same regimen exerts both powerful anticonvulsant and neuroprotectant efficacies. According to the results presented, the new strategy for establishing therapies against soman-induced seizures appears to be valid.

Citing Articles

A rapid assay for evaluating the effects of acetylcholinesterase inhibitors and reactivators in the rat basolateral amygdala.

Thinschmidt J, Harden S, King M, Talton J, Frazier C Front Cell Neurosci. 2022; 16:1066312.

PMID: 36479275 PMC: 9721344. DOI: 10.3389/fncel.2022.1066312.


HI-6-loaded PEGylated liposomes: an on-site first-aid strategy for acute organophosphorus agent poisoning.

Shen L, Zhang Y, Cai Q, Yang J, Wang Y, Quan D Drug Deliv. 2022; 30(1):20-27.

PMID: 36452996 PMC: 9721435. DOI: 10.1080/10717544.2022.2152132.


The K7 Modulator, Retigabine, is an Efficacious Antiseizure Drug for Delayed Treatment of Organophosphate-induced Status Epilepticus.

Barker B, Spampanato J, McCarren H, Berger K, Jackson C, Yeung D Neuroscience. 2021; 463:143-158.

PMID: 33836243 PMC: 8142924. DOI: 10.1016/j.neuroscience.2021.03.029.


Screening for Efficacious Anticonvulsants and Neuroprotectants in Delayed Treatment Models of Organophosphate-induced Status Epilepticus.

Barker B, Spampanato J, McCarren H, Smolik M, Jackson C, Hornung E Neuroscience. 2019; 425:280-300.

PMID: 31783100 PMC: 6935402. DOI: 10.1016/j.neuroscience.2019.11.020.


Novel therapeutics for treating organophosphate-induced status epilepticus co-morbidities, based on changes in calcium homeostasis.

Deshpande L, DeLorenzo R Neurobiol Dis. 2019; 133:104418.

PMID: 30872159 PMC: 6742584. DOI: 10.1016/j.nbd.2019.03.006.